| Name | Inspiration Healthcare Group |
|---|---|
| Epic | IHC |
| Isin | GB00BXDZL105 |
| Industry | Chemicals |
| Latest share price | 20.36p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £18.25 | Debt ratio | n/a |
| Shares in issue | 89.66 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -55.32 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -18.82 | 52-week high / low | 12.50p / 24.80p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Interim | 2023-11-23 | 2023-12-22 | 0.205p |
| Final | 2023-06-29 | 2023-07-28 | 0.41p |
| Interim | 2022-11-24 | 2022-12-28 | 0.205p |
| Final | 2022-06-30 | 2022-07-29 | 0.41p |
| Interim | 2021-11-25 | 2021-12-29 | 0.20p |
| Final | 2021-07-01 | 2021-07-30 | 0.40p |
| Interim | 2020-11-26 | 2020-12-29 | 0.20p |
| Company name | Inspiration Healthcare Group |
|---|---|
| Address | Unit 7/8 Commerce Park, Commerce Way, Croydon, United Kingdom, CR0 4YL |
| Telephone | |
| Website | http://www.inspiration-healthcare.com/# |
| Director | Position |
|---|---|
| Mr Harout Rafi | CEO |
| Mr Alan Olby | CFO |
| Ms Louise Marie Janssen-Counotte | Non-Executive Director |
| Mr Liz Shanahan | Non-Executive Director |
| Mr Richard Jones | Non-Executive Director |
| Mr Gordon Roy Davis | Executive Chairman |
| Assets £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Reporting date | 31/01/25 | 31/01/24 | 31/01/23 |
| Intangible asssets and goodwill | 5.33 | 13.28 | 17 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 15.93 | 25.99 | 30.8 |
| Inventory / work in progress | 13.08 | 13.74 | 9.94 |
| Trade and other receivables | 11.34 | 8.67 | 11.89 |
| Cash and equivalents | 0.73 | 0.41 | 2.28 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 41.08 | 49.01 | 54.89 |
| Liabilities £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Short term liabilities | 11.83 | 9.57 | 9.24 |
| Long term liabilities | 12.62 | 10.48 | 10.18 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 24.45 | 20.05 | 19.42 |
| Net assets £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net assets | 16.64 | 28.97 | 35.47 |
| Equity £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Share capital | 8.97 | 6.82 | 6.81 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 4.16 | 19.12 | 25.58 |
| Share premium account | 19.85 | 18.91 | 18.84 |
| Total equity | 16.64 | 28.97 | 35.47 |
| Income £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -14.69 | -4.93 | 0.43 |
| Pre-tax profit | -15.75 | -5.68 | 0.08 |